-
Company Insights
BNP Paribas Wealth Management: Competitor Profile, 2026
This report provides a comprehensive analysis of BNP Paribas's private banking and wealth management operations, covering its strategy, financial performance, key products and services, and brand-building activities. Headquartered in Paris, France, BNP Paribas operates in Europe, Asia, and the Middle East. It has three divisions: Corporate and Institutional Banking; Commercial, Personal Banking and Services; and Investment and Protection Services. BNP Paribas Wealth Management (BPWM) sits under the latter. It is one of the world’s leading universal banking groups.
-
Sector Analysis
Narcolepsy Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035
This report covers the 7 major markets and provides an Excel-based forecast model for the narcolepsy market through 2035 The narcolepsy therapeutics market totaled $4.6 billion in 2025 across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan). It is projected to grow rapidly at 5.5% compound annual growth rate (CAGR) to $7.8 billion by 2035, mainly driven by the entry of orexin agonists from the late-stage pipeline, the introduction of new formulations, and...
-
Company Insights
Maybank: Digital Transformation Strategies
Maybank is a financial services group with a significant presence across the ASEAN region. Its business segments are divided into three main categories: Group Community Financial Services, which offers savings, loans, and credit products; Group Global Banking, providing project financing, treasury, and investment services; and Group Insurance and Takaful, which underwrites general and life insurance, including Islamic products. The group serves a diverse customer base, including individuals, SMEs, corporates, and governments, providing tailored financial services to meet various needs. Maybank...
-
Company Insights
CIMB Group Holdings Berhad: Digital Transformation Strategies
CIMB Group Holdings Bhd (CIMB) is a provider of banking and other financial services. The group's primary activities include consumer banking, commercial banking, wholesale banking, Islamic banking, wealth management, and digital payment products and services, including loans, credit cards, cash management, bancassurance, foreign exchange, treasury services, project financing, equity-linked products, IPOs, debt restructuring, and trust services. CIMB serves a diverse customer base, offering a wide range of banking products and services for individuals, businesses, and corporates across various industries. The...
-
Company Insights
Nordea Group: Digital Transformation Strategies
Nordea Bank Abp (Nordea) is the largest financial services group in the Nordic region. The bank offers a comprehensive range of banking and financial products and services for individuals and corporate customers, including financial institutions. Nordea is organized into four business areas: Personal Banking, Business Banking, Large Corporates & Institutions, and Asset & Wealth Management, providing a full spectrum of banking, payments, financing, investment, asset management, and insurance services. The bank operates in 20 countries, maintaining a strong presence in...
-
Product Insights
Membranous Glomerulonephritis - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Membranous Glomerulonephritis - Global Clinical Trials Review, 2026" provides an overview of Membranous Glomerulonephritis Clinical trials scenario. This report provides top line data relating to the clinical trials on Membranous Glomerulonephritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2026" provides an overview of Atopic Dermatitis (Atopic Eczema) Clinical trials scenario. This report provides top line data relating to the clinical trials on Atopic Dermatitis (Atopic Eczema). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Multiple Myeloma (Kahler Disease) - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Multiple Myeloma (Kahler Disease) - Global Clinical Trials Review, 2026" provides an overview of Multiple Myeloma (Kahler Disease) Clinical trials scenario. This report provides top line data relating to the clinical trials on Multiple Myeloma (Kahler Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2026
GlobalData's clinical trial report, “Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2026" provides an overview of Duchenne Muscular Dystrophy Clinical trials scenario. This report provides top line data relating to the clinical trials on Duchenne Muscular Dystrophy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...